The Rising Prevalence Of Gastrointestinal Diseases And Its Impact On The Gastrointestinal Devices Market: A Key Catalyst Accelerating Gastrointestinal Devices Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gastrointestinal Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the past few years, the market size of gastrointestinal devices has expanded significantly. The growth is set to continue, increasing from $11.11 billion in 2024 to $11.7 billion in 2025, which equates to a compound annual growth rate (CAGR) of 5.3%. This notable growth during the historical period can be linked to factors such as progress in medical education and training, cost-effectiveness and appealing value proposition, prevalence of diseases and demographic shifts, a patient-centric viewpoint, and key regulatory breakthroughs and authorizations.

Gastrointestinal Devices Market Size Forecast: What's the Projected Valuation by 2029?
The market size of gastrointestinal devices is predicted to experience significant expansion in the upcoming years, with a projection of reaching $16.14 billion by 2029, having a compound annual growth rate (CAGR) of 8.4%. This surge in the forecast period can be credited to factors like value-based healthcare initiatives, homecare and patient-centric devices, personalized and precision medicine, global market expansion, and changes in regulations and compliance. Key trends forecasted to be prominent in this period encompass minimally invasive procedures, an increase in gastrointestinal disorders, a shift towards homecare devices, patient-focused approaches, remote monitoring, and telemedicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

What Are the Drivers Transforming the Gastrointestinal Devices Market?
The rise in gastrointestinal ailments has boosted the growth of the gastrointestinal devices market. These illnesses consist of irritable bowel syndrome, hemorrhoids, perianal abscesses, colon polyps, and cancer, among others. Based on stats from the Endoscopy Centre, every year, 62 million Americans are diagnosed with a digestive disease, and an estimated 300,000 to 500,000 Americans are afflicted with inflammatory bowel disease (IBD). The American College of Gastroenterology estimates that 10-15% of the adult population in the USA are impacted by symptoms of irritable bowel syndrome (IBS). The surge in gastrointestinal ailments has fueled the demand for gastrointestinal devices for patient treatment, thereby propelling the growth of the gastrointestinal devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3292&type=smp

Which Emerging Trends Are Transforming the Gastrointestinal Devices Market in 2025?
The growth of the gastrointestinal devices market is being impeded by the steep healthcare costs associated with treating gastrointestinal disease. As per the NEJM Journal Watch, a publication affiliated with the New England Journal of Medicine, the total healthcare spending on gastrointestinal disease amounts to roughly $136 billion per year. This surpasses the spending on heart disease ($113 billion), trauma ($103 billion), and mental health ($99 billion), demonstrating the considerable costs tied to treating gastrointestinal disease. Furthermore, the American Gastroenterological Association's database analysis reveals that patients suffering from inflammatory bowel diseases (IBDs), chronic liver diseases (CLDs), functional gastrointestinal disorders (FGIDs), gastrointestinal hemorrhage require at least one hospitalization and are high-demand and high-cost patients, accounting for a disproportionate share of hospital costs. These individuals often utilize inpatient services and need extensive attention due to functional disabilities, escalating the overall costs. High healthcare expenditure for gastrointestinal disease causes a significant portion of the population to avoid treatment outside emergency situations, which dents the growth of the gastrointestinal devices market.

Which Segments in the Gastrointestinal Devices Market Offer the Most Profit Potential?
The gastrointestinal devices market covered in this report is segmented -

1) By Product Type: GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types
2) By Sales Channel: Online Retailing, Medical Stores And Brand Outlet
3) By End Users: Hospitals, Clinics And Dialysis Centers, Ambulatory Surgical Center

Subsegments:
1) By GI Videoscopes: Flexible Videoscopes, Rigid Videoscopes
2) By Biopsy Devices: Needle Biopsy Devices, Forceps Biopsy Devices, Punch Biopsy Devices
3) By Endoscopic Retrograde Cholangiopancreatography Devices (ERCP): ERCP Cannulas, Guidewires, Balloon Sweep Devices
4) By Capsule Endoscopy: Small Intestine Capsule Endoscopes, Esophageal Capsule Endoscopes, Colonic Capsule Endoscopes
5) By Endoscopic Ultrasound: EUS Scopes, EUS-guided Fine-needle Aspiration (FNA) Devices
6) By Endoscopic Mucosal Resection (EMR): EMR Kits, EMR Suction Devices
7) By Hemostasis Devices: Mechanical Hemostasis Devices, Thermal Hemostasis Devices, Chemical Hemostasis Agents
8) By Other Product Types: Enteral Feeding Devices, Gastrostomy Tubes, Accessories For GI Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3292&type=smp

Which Firms Dominate the Gastrointestinal Devices Market by Market Share and Revenue in 2025?
Major companies operating in the gastrointestinal devices market include Johnson and Johnson Services Inc., Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton, dic*kinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Interscope Inc., Steris plc, Cook Group Incorporated, MICRO-TECH Co. Ltd., Cantel Medical Corp., CONMED Corporation, PENTAX Medical Company, Karl Storz SE & Co. KG, US Endoscopy Inc., Richard Wolf GmbH, Motus GI Holdings Inc., Congentix Medical Inc., ERBE Elektromedizin GmbH, Creo Medical Group plc, GI Dynamics Inc., Millennium Surgical Corp., Mauna Kea Technologies SA, EndoMaster Pte Ltd., Zhanjiang Bokang Biotechnology Co. Ltd., Jinshan Science & Technology Co., Safe Medical Design Inc.

Which Regions Offer the Highest Growth Potential in the Gastrointestinal Devices Market?
North America was the largest region in the gastrointestinal devices market in 2024. Asia-Pacific was the second largest region in the gastrointestinal devices market report. The regions covered in the gastrointestinal devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3292

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.